BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 37352389)

  • 1. Temporal trends and regional variability in BRAF and KRAS genetic testing in Denmark (2010-2022): Implications for precision medicine.
    Frost MG; Jensen KJ; Jimenez-Solem E; Qvortrup C; Kuhlmann TP; Andersen JL; Høgdall E; Petersen TS
    Genes Chromosomes Cancer; 2024 Apr; 63(4):e23236. PubMed ID: 38656617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of pre-diagnostic cigarette smoking on colorectal cancer survival: overall and by tumour molecular phenotype.
    Zhu Y; Yang SR; Wang PP; Savas S; Wish T; Zhao J; Green R; Woods M; Sun Z; Roebothan B; Squires J; Buehler S; Dicks E; Zhao J; Mclaughlin JR; Parfrey PS; Campbell PT
    Br J Cancer; 2014 Mar; 110(5):1359-66. PubMed ID: 24448365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of KRAS mutation on the tumor microenvironment in colorectal cancer.
    Zhou Y; Kuang Y; Wang C; Yu Y; Pan L; Hu X
    Int J Biol Sci; 2024; 20(5):1947-1964. PubMed ID: 38481800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weighting estimation in the cause-specific Cox regression with partially missing causes of failure.
    Lee J; Ogino S; Wang M
    Stat Med; 2024 Jun; 43(13):2575-2591. PubMed ID: 38659326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking-related
    Chen S; Xin J; Gu D; Li H; Zheng R; Li S; Zhang Z; Du M; Wang M
    Gut; 2024 Mar; ():. PubMed ID: 38499340
    [No Abstract]   [Full Text] [Related]  

  • 6. miR-22 promotes immunosuppression via activating JAK/STAT3 signaling in cutaneous squamous cell carcinoma.
    Yuan S; Zhu T; Wang J; Jiang R; Shu A; Zhang Z; Zhang P; Feng X; Zhao L
    Carcinogenesis; 2023 Oct; 44(7):549-561. PubMed ID: 37466677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-associated fibroblasts promote cancer stemness by inducing expression of the chromatin-modifying protein CBX4 in squamous cell carcinoma.
    Fisher ML; Balinth S; Hwangbo Y; Wu C; Ballon C; Goldberg GL; Mills AA
    Carcinogenesis; 2023 Aug; 44(6):485-496. PubMed ID: 37463322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The current landscape of therapies for hepatocellular carcinoma.
    Coffman-D'Annibale K; Xie C; Hrones DM; Ghabra S; Greten TF; Monge C
    Carcinogenesis; 2023 Oct; 44(7):537-548. PubMed ID: 37428789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA sequencing reveals the implication of the circRNA-associated ceRNA network in oesophageal squamous cell carcinoma.
    Dai S; Zhang C; Wei X; Wang X; Wen Y; Gao F; Zhao L; Shan B
    Carcinogenesis; 2023 Oct; 44(7):596-609. PubMed ID: 37402652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depletion of Gr1+ myeloid cells attenuates high-fat-diet-aggravated esophageal squamous cell carcinoma in mice.
    Jianmin P; Qinchao H; Chunyang W; Jiayu Z; Siyu W; Li W; Juan X; Bin C
    Carcinogenesis; 2023 Oct; 44(7):587-595. PubMed ID: 37352409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PABPN1 promotes clear cell renal cell carcinoma progression by suppressing the alternative polyadenylation of SGPL1 and CREG1.
    Xiong M; Liu C; Li W; Jiang H; Long W; Zhou M; Yang C; Kazobinka G; Sun Y; Zhao J; Hou T
    Carcinogenesis; 2023 Oct; 44(7):576-586. PubMed ID: 37452741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta-Analysis.
    Tosi F; Magni E; Amatu A; Mauri G; Bencardino K; Truini M; Veronese S; De Carlis L; Ferrari G; Nichelatti M; Sartore-Bianchi A; Siena S
    Clin Colorectal Cancer; 2017 Sep; 16(3):e153-e163. PubMed ID: 28216246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of anthropometric factors with KRAS and BRAF mutation status of primary colorectal cancer in men and women: a cohort study.
    Brändstedt J; Wangefjord S; Nodin B; Eberhard J; Sundström M; Manjer J; Jirström K
    PLoS One; 2014; 9(2):e98964. PubMed ID: 24918610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic factors and the risk of colorectal cancer by KRAS and BRAF mutation status.
    Myte R; Gylling B; Häggström J; Häggström C; Zingmark C; Löfgren Burström A; Palmqvist R; Van Guelpen B
    Int J Cancer; 2019 Jul; 145(2):327-337. PubMed ID: 30613980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemistry with Anti-BRAF V600E (VE1) Mouse Monoclonal Antibody is a Sensitive Method for Detection of the BRAF V600E Mutation in Colon Cancer: Evaluation of 120 Cases with and without KRAS Mutation and Literature Review.
    Dvorak K; Higgins A; Palting J; Cohen M; Brunhoeber P
    Pathol Oncol Res; 2019 Jan; 25(1):349-359. PubMed ID: 29127628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking and risk of colorectal cancer according to KRAS and BRAF mutation status in a Japanese prospective Study.
    Nakano S; Yamaji T; Shiraishi K; Hidaka A; Shimazu T; Kuchiba A; Saito M; Kunishima F; Nakaza R; Kohno T; Sawada N; Inoue M; Tsugane S; Iwasaki M
    Carcinogenesis; 2023 Aug; 44(6):476-484. PubMed ID: 37352389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes.
    Limsui D; Vierkant RA; Tillmans LS; Wang AH; Weisenberger DJ; Laird PW; Lynch CF; Anderson KE; French AJ; Haile RW; Harnack LJ; Potter JD; Slager SL; Smyrk TC; Thibodeau SN; Cerhan JR; Limburg PJ
    J Natl Cancer Inst; 2010 Jul; 102(14):1012-22. PubMed ID: 20587792
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.